---
layout: archive
title: "Patents"
permalink: /patents/
author_profile: true
---

<div class="text-justify">

  <p>
    My research often extends beyond academic publication into practical applications.  
    The following patents reflect collaborative work aimed at developing new therapeutic compounds for infectious diseases through a combination of computational modeling, medicinal chemistry, and biological validation.
  </p>

  <hr/>

  <h3>International Patent (PCT)</h3>

  <p>
    <strong>WO2023067625, Antifungal Compound, Composition and Uses Thereof</strong><br/>
    PCT/IN2022/050932, filed on 19 October 2022 and published on 27 April 2023.<br/>
    <strong>Applicants:</strong> SASTRA Deemed University, Versitech Limited<br/>
    <strong>Inventors:</strong> Neelakantan P, Solomon A P, <strong>Shanmugam K</strong><br/>
    <strong>National phase:</strong> India (2024), China (2024), United States (2025)
  </p>

  <p>
    This invention describes a novel antifungal compound and formulation with broad activity against human pathogenic fungi.  
    The compound was identified through structure-based design and validated for its ability to inhibit fungal growth and biofilm formation.  
    The work represents a collaborative effort combining computational screening and in vitro evaluation to identify next-generation antifungal candidates.
  </p>

  <hr/>

  <h3>Indian Patent</h3>

  <p>
    <strong>IN202241054663, An Anti-infective Agent, Method of Treatment, and Use Thereof</strong><br/>
    Filed on 23 September 2022 and published on 15 September 2023.<br/>
    <strong>Applicant:</strong> SASTRA Deemed University<br/>
    <strong>Inventors:</strong> Shanmugam K, Solomon A P, Neelakantan P<br/>
    <strong>Status:</strong> Awaiting examination
  </p>

  <p>
    This patent covers an anti-infective compound with antibacterial and antibiofilm properties.  
    The molecule was developed through computational docking and pharmacophore modeling and later validated using in vitro infection models.  
    The invention offers a new approach for controlling biofilm-associated infections and antibiotic resistance.
  </p>

  <hr/>

  <h3>Focus Areas</h3>
  <p>
    Drug discovery, Anti-infective compounds, Biofilm inhibition, Translational bioinformatics, Natural product chemistry
  </p>

</div>
